News
Important Only
Duke Energy Announces Key Leadership Appointments
May 2 (Reuters) - Duke Energy Corp DUK.N:DUKE ENERGY ANNOUNCES KEY LEADERSHIP APPOINTMENTSDUKE ENERGY CORP - JULIE JANSON TO RETIRE AS EVP AND CEO OF DUKE ENERGY CAROLINASDUKE ENERGY CORP - KODWO GHARTEY-TAGOE APPOINTED EVP AND CEO OF DUKE ENERGY CAROLINASReuters
Fri, May 2
MSP Recovery On April 28, Amended And Restated Nomura Note
May 2 (Reuters) - MSP Recovery Inc MSPR.O:MSP RECOVERY INC: ON APRIL 28, AMENDED AND RESTATED NOMURA NOTE TO INCREASE PRINCIPAL AMOUNT TO ABOUT $32.7 MILLIONMSP RECOVERY INC: ON APRIL 28 AMENDED AND RESTATED NOMURA NOTE TO EXTEND MATURITY DATE TO NOVEMBER 30, 2026MSP RECOVERY INC: ON MAY 1, VIRAGE ...Reuters
Fri, May 2
Karyopharm Therapeutics Inc expected to post a loss of $4.18 a share - Earnings Preview
Karyopharm Therapeutics Inc KPTI.OQ KPTI.O is expected to show a rise in quarterly revenue when it reports results on May 6 (estimated) for the period ending March 31 2025The Newton Massachusetts-based company is expected to report a 6.4% increase in revenue to $35.242 million from $33.13 million ...Reuters
Fri, May 2
Paychex Declares 10% Increase To Quarterly Cash Dividend
May 2 (Reuters) - Paychex Inc PAYX.O:PAYCHEX DECLARES A 10% INCREASE TO QUARTERLY CASH DIVIDENDPAYCHEX INC - EXPECTS TO RETURN OVER $1.4 BILLION IN DIVIDENDSPAYCHEX INC: DECLARED A REGULAR QUARTERLY CASH DIVIDEND ON PAYCHEX COMMON STOCK OF $1.08 PER SHAREReuters
Fri, May 2
Centerra Gold Inc expected to post earnings of 10 cents a share - Earnings Preview
Centerra Gold Inc CG.TO is expected to report results on May 6 for the period ending March 31 2025LSEG's mean analyst estimate for Centerra Gold Inc is for earnings of 10 cents per share. The one available analyst rating on the shares is "buy". The mean earnings estimate of analysts h...Reuters
Fri, May 2
Lindblad Expeditions Holdings Inc expected to post a loss of 14 cents a share - Earnings Preview
Lindblad Expeditions Holdings Inc LIND.OQ LIND.O is expected to show a fall in quarterly revenue when it reports results on May 6 for the period ending March 31 2025The New York City-based company is expected to report a 1.5% decrease in revenue to $151.25 million from $153.61 million a year ago, ...Reuters
Fri, May 2
Nexgen Energy Ltd expected to post a loss of 4 cents a share - Earnings Preview
Nexgen Energy Ltd NXE.TO is expected to report resultson May 6 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Nexgen Energy Ltd is for a loss of 4 cents per share. The current average analyst rating on the shares is "buy" and the breakdown of recommenda...Reuters
Fri, May 2
EXCLUSIVE-UN eyes big overhaul amid funding crisis, internal memo shows
Global body roiled by cuts from donors, including U.S.Task force suggests merging U.N. agencies to improve efficiencyUN document refers to 'duplication', bloating of senior managementSuggests relocating staff to lower-cost citiesBy Emma Farge and John Shiffman GENEVA/UNITED NATIONS, May 2...Reuters
Fri, May 2
Cartesian Therapeutics Inc expected to post a loss of 71 cents a share - Earnings Preview
Cartesian Therapeutics Inc RNAC.OQ RNAC.O is expected to show a fall in quarterly revenue when it reports results on May 6 (estimated) for the period ending March 31 2025The Frederick Maryland-based company is expected to report a 86.5% decrease in revenue to $785.71 thousand from $5.84 million a ...Reuters
Fri, May 2
CANADA RESEARCH ROUNDUP-Canadian National Railway, George Weston, Toromont Industries
May 2 (Reuters) - Securities analysts revised their ratings and price targets on several Canadian companies, including Canadian National Railway, George Weston and Toromont Industries, on Friday. HIGHLIGHTS * Bombardier BBDb.TO: CIBC raises target price to C$115 from C$106* Canadian National R...Reuters
Fri, May 2
Dupont CEO Says Not Looking At M&A Before Spinoff Is Complete: Conf Call
May 2 (Reuters) - Dupont De Nemours Inc DD.N:DUPONT CEO SAYS TARIFF-RELATED NET COST IMPACT OF $60 MILLION WILL PRIMARILY IMPACT THE SECOND HALF OF 2025: CONF CALLDUPONT EXPECTS ADJUSTED EPS OF $1.05 IN SECOND QUARTER: CONF CALLDUPONT EXPECTS NET SALES OF $3.2 BILLION IN SECOND QUARTER: CONF CALLDUP...Reuters
Fri, May 2
Marcus Corp expected to post a loss of 48 cents a share - Earnings Preview
Marcus Corp MCS.N, MCS is expected to show a rise in quarterly revenue when it reports results on May 6 for the period ending March 31 2025The Milwaukee Wisconsin-based company is expected to report a 1.0% increase in revenue to $139.894 million from $138.55 million a year ago, according to the me...Reuters
Fri, May 2
Trump says US economy in "transition," urges Fed to cut rates
May 2 (Reuters) - President Donald Trump on Friday said the U.S. economy is in a transition stage, citing strong employment and his tariff plan while reiterating his call for the U.S. Federal Reserve to lower its interest rate. "We’re only in a transition stage, just getting started!" he sai...Reuters
Fri, May 2
Fidelity National Information Services Inc expected to post earnings of $1.20 a share - Earnings Preview
Fidelity National Information Services Inc FIS.N, FIS is expected to show a rise in quarterly revenue when it reports results on May 6 for the period ending March 31 2025The Jacksonville Florida-based company is expected to report a 1.6% increase in revenue to $2.507 billion from $2.47 billion a y...Reuters
Fri, May 2
Prelude Therapeutics Inc expected to post a loss of 47 cents a share - Earnings Preview
Prelude Therapeutics Inc PRLD.OQ PRLD.O is expected to show no change in quarterly revenue when it reports results on May 5 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Prelude Therapeutics Inc is for a loss of 47 cents per share. The current average analyst ...Reuters
Fri, May 2
Street View: Eli Lilly well positioned in weight-loss market despite CVS's decision
** Eli Lilly LLY.N on Thursday downplayed CVS Health's CVS.N decision to drop the company's obesity drug Zepbound from some lists of medicines it covers for reimbursement** CVS said it would drop coverage from July 1, but keep reimbursing for rival GLP-1 weight-loss drug Wegovy after negotia...Reuters
Fri, May 2
Harmony Biosciences Holdings Inc expected to post earnings of 59 cents a share - Earnings Preview
Harmony Biosciences Holdings Inc HRMY.OQ HRMY.O is expected to show a rise in quarterly revenue when it reports results on May 6 for the period ending March 31 2025The Plymouth Meeting Pennsylvania-based company is expected to report a 18.3% increase in revenue to $182.903 million from $154.62 mil...Reuters
Fri, May 2
